A Study of GC1111 in Hunter Syndrom Patients

Clinical trial NCT03920540 · COMPLETED

Trial details

NCT number: NCT03920540
Sponsor: Green Cross Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hunter Syndrome

Start date: 2017-03-09
Primary completion: 2022-02-15
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.